Retraction
Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial
Paper Information
Record ID:
37573
Author(s):
Journal:
Publication Date:
July 19, 2021
Retraction Date:
June 08, 2022
(3.4 years years ago)
Subjects:
Broad Categories:
Medicine
Medicine
Institutions:
- Applied Biology, Inc. Irvine, CA, United States
- Department of Endocrinology, Corpometria Institute, Brasilia, Brazil
- Dermatology Department, Ramón y Cajal Hospital, Madrid, Spain
- Department of Dermatology and Venereology, University Hospital Center “Sestre Milosrdnice”, Zagreb, Croatia
- Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, NY, United States
- Sinclair Dermatology, Melbourne, VIC, Australia
- Department of Dermatology and Cutaneous Surgery, Miller School of Medicine, University of Miami, Miami, FL, United States
- School of Medicine, European University Cyprus, Nicosia, Cyprus
- Intensive Care Unit, Samel Hospital, Manaus, Brazil
- Hospital da Brigada Militar, Porto Alegre, Brazil
- Department of Dermatology, Alpert Medical School of Brown University, Providence, RI, United States
Countries:
Article Type:
Publisher:
Frontiers
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.3389/fmed.2022.964099Additional Notes:
see also: https://www.bmj.com/content/375/bmj.n2819
Citations (46)
46
Total Citations21
Post-Retraction(45.7%)
25
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
18
Within 1 year
0
After 2+ years
639
Days since retraction (latest)
Predicting drug outcome of population via clinical knowledge graph
Maria Brbić, Michihiro Yasunaga, Prabhat Agarwal et al. (4 authors)
medRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Mar 2024
3 citations
3 citations
639 days after retraction
Antiandrogens as Therapies for COVID-19: A Systematic Review
Massimiliano Cani, Samantha Epistolio, Giulia Dazio et al. (14 authors)
Cancers
Open Access
Published: Jan 2024
5 citations
5 citations
581 days after retraction
Proxalutamide reduces SARS-CoV-2 infection and associated inflammatory response
Yuanyuan Qiao, Jesse W. Wotring, Yang Zheng et al. (22 authors)
Proceedings of the National Academy of Sciences
Open Access
Published: Jul 2023
5 citations
5 citations
404 days after retraction
The Problem with Capitalism in the Trichological Sciences
Ralph M. Trüeb, Aida Gadzhigoroeva, Daisy Kopera et al. (5 authors)
International Journal of Trichology
Open Access
Published: May 2023
327 days after retraction
Androgen Drives the Expression of SARS-CoV-2 Entry Proteins in Sinonasal Tissue
Rong Rong Huang, Jenna M. Giafaglione, Takao Hashimoto et al. (12 authors)
Journal of Clinical and Translational Pathology
Open Access
Published: May 2023
327 days after retraction
Proxalutamide for the treatment of COVID‐19 rebound following Paxlovid treatment: Report of four cases and review of the literature
Dawei Yang, Min‐Jie Ju, Hao Wang et al. (7 authors)
Journal of Clinical Laboratory Analysis
Open Access
Published: Apr 2023
8 citations
8 citations
297 days after retraction
Review of therapeutic mechanisms and applications based on SARS-CoV-2 neutralizing antibodies
Mingtao Liu, Hui Gan, Zhiman Liang et al. (12 authors)
Frontiers in Microbiology
Open Access
Published: Mar 2023
14 citations
14 citations
281 days after retraction
Retraction of Clinical Trials about the SARS-CoV-2 Infection: An Unaddressed Problem and Its Possible Impact on Coronavirus Disease (COVID)-19 Treatment
Felipe Eduardo Valencise, Camila Vantini Capasso Palamim, Fernando Augusto Lima Marson
International Journal of Environmental Research and Public Health
Open Access
Published: Jan 2023
8 citations
8 citations
225 days after retraction
Drug Repurposing for COVID-19 Therapy: Pipeline, Current Status and Challenges
Rohit Verma, Shivani Raj, Umang Berry et al. (5 authors)
Unknown Journal
Published: Jan 2023
1 citation
1 citation
207 days after retraction
The Hair and Scalp in Systemic Infectious Disease
Ralph M. Trüeb, Maria Fernanda Reis Gavazzoni Dias, Hudson Dutra Rezende et al. (5 authors)
Springer eBooks
Published: Jan 2023
3 citations
3 citations
207 days after retraction
Sex hormones in SARS-CoV-2 susceptibility: key players or confounders?
Nicola Lott, Caroline E. Gebhard, Susan Bengs et al. (7 authors)
Nature Reviews Endocrinology
Open Access
Published: Dec 2022
29 citations
29 citations
184 days after retraction
Small molecules in the treatment of COVID-19
Sibei Lei, Xiaohua Chen, Jieping Wu et al. (5 authors)
Signal Transduction and Targeted Therapy
Open Access
Published: Dec 2022
88 citations
88 citations
180 days after retraction
Testosterone suppression combined with high dose estrogen as potential treatment of SARS-CoV-2. A mini review
Herjan J.T. Coelingh Bennink, Jan F M Egberts, F.M.J. Debruyne
Heliyon
Open Access
Published: Dec 2022
1 citation
1 citation
176 days after retraction
Impact of gender-affirming hormone therapy on the development of COVID-19 infections and associated complications: A systematic review
Jennifer Ferraro, Allie Reynolds, Sylvia Edoigiawerie et al. (7 authors)
World Journal of Methodology
Open Access
Published: Nov 2022
3 citations
3 citations
161 days after retraction
Drug repositioning approach to target viral and host cells in terms of COVID-19 treatment: A review of in vivo experiments and clinical studies
Ali SHAHALI, Vajihe AKBARI, Rasool SOLTANI et al. (5 authors)
Journal of Experimental and Clinical Medicine
Open Access
Published: Oct 2022
143 days after retraction
Androgens’ Role in Severity and Mortality Rates of COVID-19
Ali Ataei, Mohammad Moein Derakhshan, Mohadese Razmjooie et al. (10 authors)
Hormone and Metabolic Research
Open Access
Published: Oct 2022
5 citations
5 citations
118 days after retraction
The precision medicine process for treating rare disease using the artificial intelligence tool mediKanren
Aleksandra Foksinska, Camerron M. Crowder, Andrew B. Crouse et al. (14 authors)
Frontiers in Artificial Intelligence
Open Access
Published: Sep 2022
42 citations
42 citations
114 days after retraction
Recent advances in small-molecular therapeutics for COVID-19
Lei Zhong, Zhipeng Zhao, Xuerun Peng et al. (5 authors)
Precision Clinical Medicine
Open Access
Published: Sep 2022
23 citations
23 citations
108 days after retraction
Research and development of Chinese anti-COVID-19 drugs
Xiwei Ji, Xiangrui Meng, Xiao Zhu et al. (5 authors)
Acta Pharmaceutica Sinica B
Open Access
Published: Sep 2022
19 citations
19 citations
97 days after retraction
SARS-CoV-2 vaccination in androgen sensitive phenotypes – A study on associated factors for SARS-CoV-2 vaccination and its adverse effects among androgenetic alopecia and benign prostate hyperplasia patients
Zhihua Fan, Shixin Duan, Fangfen Liu et al. (11 authors)
Frontiers in Immunology
Open Access
Published: Sep 2022
1 citation
1 citation
86 days after retraction
Need for a Standardized Translational Drug Development Platform: Lessons Learned from the Repurposing of Drugs for COVID-19
Frauke Assmus, Jean‐Sélim Driouich, Rana Abdelnabi et al. (31 authors)
Microorganisms
Open Access
Published: Aug 2022
7 citations
7 citations
65 days after retraction
Stem Cell‐Based Models for Studying the Effects of Cancer and Cancer Therapies on the Peripheral Nervous System
Mikayla N Richter, Faranak Fattahi
Advanced Biology
Open Access
Published: Jun 2022
3 citations
3 citations
4 days before retraction
Higher premorbid serum testosterone predicts COVID-19-related mortality risk in men
Bu B. Yeap, Ross J. Marriott, Laurens Manning et al. (8 authors)
European Journal of Endocrinology
Open Access
Published: May 2022
12 citations
12 citations
29 days before retraction
The immune response to <scp>COVID</scp>‐19: Does sex matter?
Jim Q. Ho, Mohammad Reza Sepand, Banafsheh Bigdelou et al. (10 authors)
Immunology
Open Access
Published: Apr 2022
36 citations
36 citations
43 days before retraction
Effect of Androgen Suppression on Clinical Outcomes in Hospitalized Men With COVID-19
Nicholas G. Nickols, Zhibao Mi, Ellen DeMatt et al. (34 authors)
JAMA Network Open
Open Access
Published: Apr 2022
25 citations
25 citations
50 days before retraction
The Fragility of Statistically Significant Results in Randomized Clinical Trials for COVID-19
Takahiro Itaya, Yotsuha Isobe, Sayoko Suzuki et al. (6 authors)
JAMA Network Open
Open Access
Published: Mar 2022
22 citations
22 citations
82 days before retraction
Fluorine in Medicinal Chemistry: In Perspective to COVID-19
Cheng Zhang
Unknown Journal
Open Access
Published: Mar 2022
98 days before retraction
Reply to Carlos G. Wambier and Gerard J. Nau’s Letter to the Editor re: Karin Welén, Ebba Rosendal, Magnus Gisslén, et al. A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome: No Evidence of Benefit, Supported by Epidemiology and In Vitro Data. Eur Urol. 2022;81:285–93. Positive Effects of Enzalutamide for Hospitalized COVID-19 Patients
Karin Welén, Ebba Rosendal, Eva Freyhult et al. (9 authors)
European Urology
Open Access
Published: Feb 2022
2 citations
2 citations
105 days before retraction
Alopecia in patients with COVID-19: A systematic review and meta-analysis
Betty Nguyen, Antonellá Tosti
JAAD International
Open Access
Published: Feb 2022
55 citations
55 citations
106 days before retraction
Ofeleein i mi Vlaptin—Volume II: Immunity Following Infection or mRNA Vaccination, Drug Therapies and Non-Pharmacological Management at Post-Two Years SARS-CoV-2 Pandemic
Jannis Kountouras, Dimitra Gialamprinou, Georgios Kotronis et al. (11 authors)
Medicina
Open Access
Published: Feb 2022
6 citations
6 citations
111 days before retraction
Little support for a protective effect of ADT against COVID-19
Andreas Josefsson
Scandinavian Journal of Urology
Open Access
Published: Feb 2022
3 citations
3 citations
119 days before retraction
“MATH+” Multi-Modal Hospital Treatment Protocol for COVID-19 Infection: Clinical and Scientific Rationale
Pierre Kory, G. Umberto Meduri, José Iglesias et al. (6 authors)
Journal of Clinical Medicine Research
Open Access
Published: Feb 2022
7 citations
7 citations
127 days before retraction
Final Results of a Randomized, Placebo-Controlled, Two-Arm, Parallel Clinical Trial of Proxalutamide for Hospitalized COVID-19 Patients: A Multiregional, Joint Analysis of the Proxa-Rescue AndroCoV Trial
Flavio Cadegiani, Ricardo Ariel Zimerman, Daniel Fonseca et al. (15 authors)
Cureus
Open Access
Published: Dec 2021
25 citations
25 citations
165 days before retraction
A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome: No Evidence of Benefit, Supported by Epidemiology and In Vitro Data
Karin Welén, Ebba Rosendal, Magnus Gisslén et al. (27 authors)
European Urology
Open Access
Published: Dec 2021
55 citations
55 citations
175 days before retraction
Correlation Between Nongenomic Action of C19-Steroids and COVID-19 Severity
Mercedes Perusquı́a
Physiological Research
Open Access
Published: Dec 2021
3 citations
3 citations
176 days before retraction
EXOGENOUS Sex Hormones and Sex Hormone Receptor Modulators in COVID‐19: Rationale and Clinical Pharmacology Considerations
Peng Zou, Agiua Heath, Catherine Sewell et al. (6 authors)
Clinical Pharmacology & Therapeutics
Published: Dec 2021
4 citations
4 citations
180 days before retraction
Synthesis and evaluation of enantiomers of hydroxychloroquine against SARS-CoV-2 in vitro
Yong Ni, Jinbiao Liao, Zhenlong Qian et al. (8 authors)
Bioorganic & Medicinal Chemistry
Open Access
Published: Nov 2021
16 citations
16 citations
198 days before retraction
Races of small molecule clinical trials for the treatment of COVID‐19: An up‐to‐date comprehensive review
Suwen Hu, Songwei Jiang, Qi Xiang et al. (6 authors)
Drug Development Research
Open Access
Published: Nov 2021
73 citations
73 citations
209 days before retraction
Are sex hormones promising candidates to explain sex disparities in the COVID-19 pandemic?
Maria Luisa Brandi
Reviews in Endocrine and Metabolic Disorders
Open Access
Published: Nov 2021
33 citations
33 citations
210 days before retraction
Clinical drug therapies and biologicals currently used or in clinical trial to treat COVID-19
Rory J. Malek, Colin A. Bill, Charlotte M. Vines
Biomedicine & Pharmacotherapy
Open Access
Published: Oct 2021
10 citations
10 citations
249 days before retraction
Efficacy and safety of current medications for treating severe and non-severe COVID-19 patients: an updated network meta-analysis of randomized placebo-controlled trials
Qinglin Cheng, Chen Jun-fang, Qingjun Jia et al. (5 authors)
Aging
Open Access
Published: Sep 2021
23 citations
23 citations
265 days before retraction
Proxalutamide Improves Inflammatory, Immunologic, and Thrombogenic Markers in Mild-to-Moderate COVID-19 Males and Females: an Exploratory Analysis of a Randomized, Double-Blinded, Placebo-Controlled Trial Early Antiandrogen Therapy (EAT) with Proxalutamide (The EAT-Proxa Biochemical AndroCoV-Trial)
Flavio Cadegiani, Andy Goren, Carlos Gustavo Wambier et al. (4 authors)
medRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Jul 2021
6 citations
6 citations
318 days before retraction
Proxalutamide (GT0918) Reduces the Rate of Hospitalization in mild-to-moderate COVID-19 Female Patients: A Randomized Double-Blinded Placebo-Controlled Two-Arm Parallel Trial
Flavio Cadegiani, Ricardo Ariel Zimerman, Daniel do Nascimento Fonseca et al. (7 authors)
medRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Jul 2021
9 citations
9 citations
333 days before retraction
Proxalutamide Reduction of Mortality Rate in Hospitalized COVID-19 Patients Depends on Treatment Duration – an Exploratory Analysis of the Proxa-Rescue AndroCoV Trial
Ricardo Ariel Zimerman, Daniel do Nascimento Fonseca, Michael do Nascimento Correia et al. (18 authors)
medRxiv (Cold Spring Harbor Laboratory)
Published: Jul 2021
5 citations
5 citations
341 days before retraction
Proxalutamide Improves Lung Injury in Hospitalized COVID-19 Patients – an Analysis of the Radiological Findings of the Proxa-Rescue AndroCoV Trial
Flavio Cadegiani, Daniel do Nascimento Fonseca, Michael do Nascimento Correia et al. (18 authors)
medRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Jul 2021
4 citations
4 citations
341 days before retraction
Efficacy of Proxalutamide in Hospitalized COVID-19 Patients: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Design Clinical Trial
Flavio Cadegiani, Daniel do Nascimento Fonseca, John McCoy et al. (30 authors)
medRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Jun 2021
11 citations
11 citations
351 days before retraction
Related Records
This article has multiple records in the database due to different notices:
Record #37574
Jan 17, 2022Quick Stats
Total Citations:
46
Years Since Retraction:
3.4 years
Open Access:
Yes
Last Checked:
Jul 24, 2025